Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteonecrosis × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Lymphoid 2 Sarcoma 1 Plasma cell 1

Conditions

Multiple Myeloma 2741 Neoplasms, Plasma Cell 549 Lymphoma 406 Lymphoma, Non-Hodgkin 385 Hodgkin Disease 323 Recurrence 321 Leukemia, Lymphocytic, Chronic, B-Cell 318 Precursor Cell Lymphoblastic Leukemia-Lymphoma 298 Leukemia 290 Leukemia, Myeloid, Acute 282 Myelodysplastic Syndromes 257 Lymphoma, Mantle-Cell 230 Lymphoma, Large B-Cell, Diffuse 225 Lymphoma, Follicular 222 Lymphoma, B-Cell, Marginal Zone 201 Burkitt Lymphoma 198 Lymphoma, Large-Cell, Immunoblastic 180 Myeloproliferative Disorders 178 Immunoglobulin Light-chain Amyloidosis 159 Neoplasms 156 Primary Myelofibrosis 152 Hematologic Neoplasms 150 Leukemia, Myeloid, Chronic-Phase 143 Leukemia, Myeloid, Accelerated Phase 136 Lymphoma, T-Cell, Cutaneous 134 Blast Crisis 128 Leukemia, Myelomonocytic, Chronic 125 Waldenstrom Macroglobulinemia 122 Mycosis Fungoides 113 Sezary Syndrome 112

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02286830 2023-02-17

Magnolia

Odense University Hospital

Phase 4 Completed

Multiple Myeloma, Osteolysis, Osteonecrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡